Yokoya, Yuta
Igarashi, Ataru
Uda, Akihito
Deguchi, Hisato
Takeuchi, Toshihisa http://orcid.org/0000-0002-1233-0977
Higuchi, Kazuhide
Funding for this research was provided by:
Takeda Pharmaceutical Company
Article History
Received: 26 April 2019
Accepted: 31 July 2019
First Online: 8 August 2019
Compliance with ethical standards
:
: Ataru Igarashi received consulting fees from Novartis Pharma K. K., AbbVie GK, Milliman, Sony Inc., and Eli Lilly Japan K. K., and lecture fees from Chugai Pharmaceutical Company, Ltd., CRECON Research and Consulting Inc., Terumo Corporation, Bristol-Myers Squibb K. K., and Creativ Ceutical K. K. Ataru Igarashi also received research grants from Pfizer Japan Inc., CSL Behring Japan Inc., Gilead Science K. K., and Fuji Film K. K. Akihito Uda and Hisato Deguchi are employees of Takeda Pharmaceutical Company Ltd. Toshihisa Takeuchi received honoraria from AstraZeneca K.K., Daiichi Sankyo Company, Ltd., and Takeda Pharmaceutical Company, Ltd. Toshihisa Takeuchi also received research funding from AstraZeneca K.K. Kazuhide Higuchi received research honoraria and research funding from Takeda Pharmaceutical Company, Ltd., Otsuka Pharmaceutical Company, Ltd., AstraZeneca K.K., Daiichi Sankyo Company, Ltd., and Eisai Company, Ltd. Yuta Yokoya has no conflicts of interest to declare.